GeneDx · 1 day ago
Clinical Molecular Geneticist (ABMGG Board Eligible or Board Certified, $5k Sign-On Bonus)
GeneDx is a leader in precision medicine focused on diagnosing rare diseases. They are seeking a Senior Clinical Scientist to leverage expertise in genomic data analysis to drive clinical insights and improve patient care.
AnalyticsArtificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedicalPredictive Analytics
Responsibilities
Decode the rare and the complex: perform clinical data analysis, identifying potentially disease associated variants, by integrating molecular variant assessment with your clinical expertise
Own the case: drive each case forward by transforming complex genomic data into clinically meaningful insights
Collaborate to lead: work closely with geneticists, genetic counselors, molecular biologists, and bioinformaticians
Push the science forward: contribute to internal knowledge sharing and continuous workflow improvement
Be part of the conversation: participate in team discussions and provide clinical input on patient level interpretation
Be accountable: review and sign out detailed clinical reports with confidence and care
Qualification
Required
PhD, MD, or DO degree
ABMGG board certification or eligibility in Clinical Molecular Genetics and Genomics, Laboratory Genetics and Genomics, or Clinical Genetics and Genomics
Strong foundation in human genetics and variant interpretation
Familiarity with NGS analysis, molecular test design, and online genomics resources
Excellent judgment, communication, and time management skills — the kind that inspire confidence and trust
Preferred
2+ years in a clinical diagnostics setting preferred
Benefits
Paid Time Off (PTO)
Health, Dental, Vision and Life insurance
401k Retirement Savings Plan
Employee Discounts
Voluntary benefits
Company
GeneDx
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Funding
Current Stage
Public CompanyTotal Funding
$941MKey Investors
BlackRock Innovation Capital
2023-01-26Post Ipo Equity· $150M
2023-01-10IPO
2022-01-18Post Ipo Equity· $200M
Recent News
Company data provided by crunchbase